{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30338847", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "05"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "12", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1111/bph.14521"], "Journal": {"ISSN": "1476-5381", "JournalIssue": {"Volume": "176", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Jan"}}, "Title": "British journal of pharmacology", "ISOAbbreviation": "Br J Pharmacol"}, "ArticleTitle": "Seselin ameliorates inflammation via targeting Jak2 to suppress the proinflammatory phenotype of macrophages.", "Pagination": {"StartPage": "317", "EndPage": "333", "MedlinePgn": "317-333"}, "Abstract": {"AbstractText": ["Sepsis is a serious clinical condition with a high mortality rate. Anti inflammatory agents have been found to be beneficial for the treatment of sepsis. Here, we have evaluated the anti-inflammatory activity of seselin in models of sepsis and investigated the underlying molecular mechanism(s).", "In vivo therapeutic effects of seselin was evaluated in two models of sepsis, caecal ligation and puncture or injection of LPS, in C57BL/6 mice. In vitro, anti-inflammatory activity of seselin was assessed with macrophages stimulated with LPS and IFN-\u03b3. Anti inflammatory actions were analysed with immunohistochemical methods, ELISA and Western blotting. Flow cytometry was used to assess markers of macrophage phenotype (pro- or anti-inflammatory). Other methods used included co-immunoprecipitation, cellular thermal shift assay and molecular docking.", "In vivo, seselin clearly ameliorated sepsis induced by caecal ligation and puncture. In lung tissue from septic mice and in cultured macrophages, seselin down-regulated levels of proinflammatory factors and activity of STAT1 and p65, the master signal pathway molecules for polarization of macrophages into the proinflammatory phenotype. Importantly, adoptive transfer of bone marrow-derived macrophages, pretreated with seselin, lowered systemic proinflammatory factors in mice challenged with LPS. The underlying mechanism was that seselin targeted Jak2 to block interaction with IFN\u03b3 receptors and downstream STAT1.", "Seselin exhibited anti-inflammatory activity through its action on Jak2. These results indicated a possible application of seselin to the treatment of inflammatory disease via blocking the development of the proinflammatory phenotype of macrophages."], "CopyrightInformation": "\u00a9 2018 The British Pharmacological Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Feng", "ForeName": "Lili", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Sun", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jiangsu Centre for Research and Development of Medicinal Plants, Institute of Botany Jiangsu Province, Chinese Academy of Sciences, Nanjing, China."}], "LastName": "Song", "ForeName": "Pingping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Xu", "ForeName": "Lisha", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Wu", "ForeName": "Xingxin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Wu", "ForeName": "Xuefeng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Shen", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Sun", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": ["0000-0003-0965-736X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Kong", "ForeName": "Lingdong", "Initials": "L"}, {"Identifier": ["0000-0003-2260-035X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Wu", "ForeName": "Xudong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Xu", "ForeName": "Qiang", "Initials": "Q"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Br J Pharmacol", "NlmUniqueID": "7502536", "ISSNLinking": "0007-1188"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Interferon"}, {"RegistryNumber": "0", "NameOfSubstance": "STAT1 Transcription Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "Stat1 protein, mouse"}, {"RegistryNumber": "5634E8957P", "NameOfSubstance": "seselin"}, {"RegistryNumber": "EC 2.7.10.2", "NameOfSubstance": "Jak2 protein, mouse"}, {"RegistryNumber": "EC 2.7.10.2", "NameOfSubstance": "Janus Kinase 2"}], "CommentsCorrectionsList": [{"RefSource": "Br J Pharmacol. 2023 Mar;180(5):681. doi: 10.1111/bph.16022", "PMID": "36788784"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Coumarins"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Janus Kinase 2"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Phenotype"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Receptors, Interferon"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "STAT1 Transcription Factor"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Sepsis"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aggarwal NR, King LS, D'Alessio FR (2014). Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol 306: L709\u2013L725.", "ArticleIdList": ["PMC3989724", "24508730"]}, {"Citation": "Aldo PB, Craveiro V, Guller S, Mor G (2013). Effect of culture conditions on the phenotype of THP\u20101 monocyte cell line. American journal of reproductive immunology (New York, NY: 1989) 70: 80\u201386.", "ArticleIdList": ["PMC3703650", "23621670"]}, {"Citation": "Alexander SPH, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E et al (2017a). The Concise Guide to PHARMACOLOGY 2017/18: Enzymes. Br J Pharmacol 174 (Suppl. 1): S272\u2013S359.", "ArticleIdList": ["PMC5650666", "29055034"]}, {"Citation": "Alexander SPH, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD et al (2017b). The Concise Guide to PHARMACOLOGY 2017/18: Other proteins. Br J Pharmacol 174 (Suppl. 1): S1\u2013S16.", "ArticleIdList": ["PMC5650669", "29055035"]}, {"Citation": "Alexander SPH, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E et al (2017c). The Concise Guide to PHARMACOLOGY 2017/18: Catalytic receptors. Br J Pharmacol 174: S225\u2013S271.", "ArticleIdList": ["PMC5650661", "29055036"]}, {"Citation": "Alvarez\u2010Errico D, Vento\u2010Tormo R, Sieweke M, Ballestar E (2015). Epigenetic control of myeloid cell differentiation, identity and function. Nat Rev Immunol 15: 7\u201317.", "ArticleIdList": ["25534619"]}, {"Citation": "Anand P, Singh B, Singh N (2012). A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem 20: 1175\u20131180.", "ArticleIdList": ["22257528"]}, {"Citation": "Andraos R, Qian Z, Bonenfant D, Rubert J, Vangrevelinghe E, Scheufler C et al (2012). Modulation of activation\u2010loop phosphorylation by JAK inhibitors is binding mode dependent. Cancer Discov 2: 512\u2013523.", "ArticleIdList": ["PMC5022112", "22684457"]}, {"Citation": "Barot KP, Jain SV, Kremer L, Singh S, Ghate MD (2015). Recent advances and therapeutic journey of coumarins: current status and perspectives. Med Chem Res 24: 2771\u20132798."}, {"Citation": "Benoit M, Desnues B, Mege JL (2008). Macrophage polarization in bacterial infections. J Immunol 181: 3733\u20133739.", "ArticleIdList": ["18768823"]}, {"Citation": "Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN et al (2007). Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11: R49.", "ArticleIdList": ["PMC2206478", "17448250"]}, {"Citation": "Buras J, Holzmann B, Sitkovsky M (2005). Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854\u2013865.", "ArticleIdList": ["16224456"]}, {"Citation": "Cardenas\u2010Ortega NC, Perez\u2010Gonzalez C, Zavala\u2010Sanchez MA, Hernandez\u2010Ramirez AB, Perez\u2010Gutierrez S (2007). Antifungal activity of seselin in protecting stored maize from Aspergillus flavus. Asian J Plant Sci 6 (4): 712\u2013714."}, {"Citation": "Cervantes F, Vannucchi AM, Kiladjian JJ, Al\u2010Ali HK, Sirulnik A, Stalbovskaya V et al (2013). Three\u2010year efficacy, safety, and survival findings from COMFORT\u2010II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis. Blood 122: 4047\u20134053.", "ArticleIdList": ["24174625"]}, {"Citation": "Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA et al (2018). Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Brit J Pharmacol 175: 987\u2013993.", "ArticleIdList": ["PMC5843711", "29520785"]}, {"Citation": "Feng L, Song P, Zhou H, Li A, Ma Y, Zhang X et al (2014). Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice. Biochem Pharmacol 89: 109\u2013118.", "ArticleIdList": ["24607272"]}, {"Citation": "Fleischmann R, Kremer J, Cush J, Schulze\u2010Koops H, Connell CA, Bradley JD et al (2012). Placebo\u2010controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N Engl J Med 367: 495\u2013507.", "ArticleIdList": ["22873530"]}, {"Citation": "Fujishima S (2016). Organ dysfunction as a new standard for defining sepsis. Inflamm Regen 36: 24.", "ArticleIdList": ["PMC5725936", "29259697"]}, {"Citation": "Garcia\u2010Argaez AN, Apan TOR, Delgado HP, Vel\u00e1zquez G, Mart\u00ednez\u2010V\u00e1zquez M (2000). Anti\u2010inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Planta Med 66: 279\u2013281.", "ArticleIdList": ["10821059"]}, {"Citation": "Geyer HL, Mesa RA (2014). Therapy for myeloproliferative neoplasms: when, which agent, and how? Blood 124: 3529\u20133537.", "ArticleIdList": ["25472969"]}, {"Citation": "Glass CK, Natoli G (2016). Molecular control of activation and priming in macrophages. Nat Immunol 17: 26\u201333.", "ArticleIdList": ["PMC4795476", "26681459"]}, {"Citation": "Gomez\u2010Outes A, Suarez\u2010Gea ML, Calvo\u2010Rojas G, Lecumberri R, Rocha E, Pozo\u2010Hernandez C et al (2012). Discovery of anticoagulant drugs: a historical perspective. Curr Drug Discov Technol 9: 83\u2013104.", "ArticleIdList": ["21838662"]}, {"Citation": "Goren R, Tomer E (1971). Effects of seselin and coumarin on growth, indoleacetic acid oxidase, and peroxidase, with special reference to cucumber (Cucumis sativa L.) radicles. Plant Physiol 47: 312\u2013316.", "ArticleIdList": ["PMC365860", "16657614"]}, {"Citation": "Grover J, Jachak SM (2015). Coumarins as privileged scaffold for anti\u2010inflammatory drug development. RSC Adv 5: 38892\u201338905."}, {"Citation": "Guth AM, Janssen WJ, Bosio CM, Crouch EC, Henson PM, Dow SW (2009). Lung environment determines unique phenotype of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 296: L936\u2013L946.", "ArticleIdList": ["PMC2692811", "19304907"]}, {"Citation": "Harding SD, Sharman JL, Faccenda E, Southan C, Pawson AJ, Ireland S et al (2018). The IUPHAR/BPS guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology. Nucl Acids Res 46: D1091\u2013D1106.", "ArticleIdList": ["PMC5753190", "29149325"]}, {"Citation": "Hernanz R, Martinez\u2010Revelles S, Palacios R, Martin A, Cachofeiro V, Aguado A et al (2015). Toll\u2010like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II\u2010induced hypertension. Br J Pharmacol 172: 3159\u20133176.", "ArticleIdList": ["PMC4459031", "25712370"]}, {"Citation": "Ivashkiv LB, Donlin LT (2014). Regulation of type I interferon responses. Nat Rev Immunol 14: 36\u201349.", "ArticleIdList": ["PMC4084561", "24362405"]}, {"Citation": "Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P et al (2014). The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc 9: 2100\u20132122.", "ArticleIdList": ["25101824"]}, {"Citation": "Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E et al (2015). Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42: 419\u2013430.", "ArticleIdList": ["25786174"]}, {"Citation": "Kasahara K, Matsumura Y, Ui K, Kasahara K, Komatsu Y, Mikasa K et al (2012). Intranasal priming of newborn mice with microbial extracts increases opsonic factors and mature CD11c+ cells in the airway. Am J Physiol Lung Cell Mol Physiol 303: L834\u2013L843.", "ArticleIdList": ["22923643"]}, {"Citation": "Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577\u20131579.", "ArticleIdList": ["PMC2936830", "20649561"]}, {"Citation": "Kopf M, Schneider C, Nobs SP (2015). The development and function of lung\u2010resident macrophages and dendritic cells. Nat Immunol 16: 36\u201344.", "ArticleIdList": ["25521683"]}, {"Citation": "Koppikar P, Bhagwat N, Kilpivaara O, Manshouri T, Adli M, Hricik T et al (2012). Heterodimeric JAK\u2010STAT activation as a mechanism of persistence to JAK2 inhibitor therapy. Nature 489: 155\u2013159.", "ArticleIdList": ["PMC3991463", "22820254"]}, {"Citation": "Kostova I, Bhatia S, Grigorov P, Balkansky S, Parmar VS, Prasad AK et al (2011). Coumarins as antioxidants. Curr Med Chem 18: 3929\u20133951.", "ArticleIdList": ["21824098"]}, {"Citation": "Kotas ME, Medzhitov R (2015). Homeostasis, inflammation, and disease susceptibility. Cell 160: 816\u2013827.", "ArticleIdList": ["PMC4369762", "25723161"]}, {"Citation": "Lawrence T, Natoli G (2011). Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11: 750\u2013761.", "ArticleIdList": ["22025054"]}, {"Citation": "Lima V, Silva CB, Mafezoli J, Bezerra MM, Moraes MO, Mour\u00e3o GS et al (2006). Antinociceptive activity of the pyranocoumarin seselin in mice. Fitoterapia 77: 574\u2013578.", "ArticleIdList": ["17055189"]}, {"Citation": "Martin GS, Mannino DM, Eaton S, Moss M (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546\u20131554.", "ArticleIdList": ["12700374"]}, {"Citation": "Matsunaga N, Tsuchimori N, Matsumoto T, Ii M (2011). TAK\u2010242 (resatorvid), a small\u2010molecule inhibitor of Toll\u2010like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol 79: 34\u201341.", "ArticleIdList": ["20881006"]}, {"Citation": "McGrath JC, Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189\u20133193.", "ArticleIdList": ["PMC4500358", "25964986"]}, {"Citation": "Melliou E, Magiatis P, Mitaku S, Skaltsounis AL, Chinou E, Chinou I (2005). Natural and synthetic 2,2\u2010dimethylpyranocoumarins with antibacterial activity. J Nat Prod 68: 78\u201382.", "ArticleIdList": ["15679322"]}, {"Citation": "Meyer SC, Keller MD, Chiu S, Koppikar P, Guryanova OA, Rapaport F et al (2015). CHZ868, a Type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms. Cancer Cell 28: 15\u201328.", "ArticleIdList": ["PMC4503933", "26175413"]}, {"Citation": "Meylan E, Tschopp J, Karin M (2006). Intracellular pattern recognition receptors in the host response. Nature 442: 39\u201344.", "ArticleIdList": ["16823444"]}, {"Citation": "O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A (2015). The JAK\u2010STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66: 311\u2013328.", "ArticleIdList": ["PMC5634336", "25587654"]}, {"Citation": "Piccolo V, Curina A, Genua M, Ghisletti S, Simonatto M, Sabo A et al (2017). Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross\u2010talk. Nat Immunol 18: 530\u2013540.", "ArticleIdList": ["PMC5524187", "28288101"]}, {"Citation": "Rittirsch D, Hoesel LM, Ward PA (2007). The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 81: 137\u2013143.", "ArticleIdList": ["17020929"]}, {"Citation": "Rittirsch D, Huber\u2010Lang MS, Flierl MA, Ward PA (2008). Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4: 31.", "ArticleIdList": ["PMC2754226", "19131954"]}, {"Citation": "Riveiro ME, De Kimpe N, Moglioni A, Vazquez R, Monczor F, Shayo C et al (2010). Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 17: 1325\u20131338.", "ArticleIdList": ["20166938"]}, {"Citation": "Rodgaard\u2010Hansen S, Rafique A, Christensen PA, Maniecki MB, Sandahl TD, Nexo E et al (2014). A soluble form of the macrophage\u2010related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med 52: 453\u2013461.", "ArticleIdList": ["24114918"]}, {"Citation": "Schwende H, Fitzke E, Ambs P, Dieter P (1996). Differences in the state of differentiation of THP\u20101 cells induced by phorbol ester and 1,25\u2010dihydroxyvitamin D3. J Leukoc Biol 59: 555\u2013561.", "ArticleIdList": ["8613704"]}, {"Citation": "Sica A, Mantovani A (2012). Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787\u2013795.", "ArticleIdList": ["PMC3287223", "22378047"]}, {"Citation": "Siriwardhana A, Wijesundara S, Karunaratne V (2015). A review of studies on bioactive compounds isolated from Sri Lankan flora. J Natl Sci Found 43: 11."}, {"Citation": "Spellberg B, Edwards JE (2002). The pathophysiology and treatment of Candida sepsis. Curr Infect Dis Rep 4: 387\u2013399.", "ArticleIdList": ["12228025"]}, {"Citation": "Stark GR, Darnell JE Jr (2012). The JAK\u2010STAT pathway at twenty. Immunity 36: 503\u2013514.", "ArticleIdList": ["PMC3909993", "22520844"]}, {"Citation": "Stearns\u2010Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG (2011). The pathogenesis of sepsis. Annu Rev Pathol 6: 19\u201348.", "ArticleIdList": ["PMC3684427", "20887193"]}, {"Citation": "Vera B, Rodriguez AD, La Clair JJ (2011). Aplysqualenol A binds to the light chain of dynein type 1 (DYNLL1). Angew Chem Int Ed Engl 50: 8134\u20138138.", "ArticleIdList": ["PMC3582901", "21744448"]}, {"Citation": "Villarino AV, Kanno Y, O'Shea JJ (2017). Mechanisms and consequences of Jak\u2010STAT signaling in the immune system. Nat Immunol 18: 374\u2013384.", "ArticleIdList": ["28323260"]}, {"Citation": "Xu G, Feng L, Song P, Xu F, Li A, Wang Y et al (2016). Isomeranzin suppresses inflammation by inhibiting M1 macrophage polarization through the NF\u2010\u03baB and ERK pathway. Int Immunopharmacol 38: 175\u2013185.", "ArticleIdList": ["27285671"]}, {"Citation": "Yarilina A, Park\u2010Min KH, Antoniv T, Hu X, Ivashkiv LB (2008). TNF activates an IRF1\u2010dependent autocrine loop leading to sustained expression of chemokines and STAT1\u2010dependent type I interferon\u2010response genes. Nat Immunol 9: 378\u2013387.", "ArticleIdList": ["18345002"]}, {"Citation": "Yu YR, O'Koren EG, Hotten DF, Kan MJ, Kopin D, Nelson ER et al (2016). A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non\u2010lymphoid tissues. PloS one 11: e0150606.", "ArticleIdList": ["PMC4777539", "26938654"]}]}], "History": [{"Year": "2018", "Month": "3", "Day": "27"}, {"Year": "2018", "Month": "8", "Day": "23"}, {"Year": "2018", "Month": "9", "Day": "24"}, {"Year": "2018", "Month": "10", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30338847", "PMC6295420", "10.1111/bph.14521"]}}]}